Acacia to buy portfolio of 19 companies
Concerns over Facebook and Google behind move
Vital signs to the past?
Shifting to areas less affected by crisis
Biggest changes from the pandemic
Just 10% of investors anticipate V-shaped recovery
To help Schroders rebalance portfolio
Eye on large-cap pharma and biotech
Backs China vs US post-recovery
After a torrid three weeks, financial markets stabilised in recent days in response to the stimulus packages announced both by central banks and governments.
Up to 51% of dividends could be cut
AI, telemedicine and medical devices
Outlooks for the biotech sector
Three key drivers of change
Last year's contraction of manufacturing and industrial output was the third of the current economic cycle, influenced by dollar strength, the trade war, and the impact of strikes at General Motors and the grounding of the Boeing 737 Max.
Identifying resilient themes
Tenpin, emerging markets and Alphabet
In the US, one exciting opportunity is in sustainable packaging, where volumes are moving meaningfully toward aluminium, which is infinitely recyclable and should have a lower overall life cycle impact compared to plastic.
Finding cure for cancer through investing
Six positions added to portfolio in 2019
ETFs now $6.3trn industry
Finding companies ahead of the growth trend
5G, pharma, data and fuel efficiency
Focus on medical cannabis